B. Calmels

发表

[CAR-T cells: Lymphocytes that express a chimeric antigen receptor].

R. Bouabdallah, D. Blaise, C. Chabannon, 2019, La Revue de medecine interne.

Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.

D. Blaise, Wang LiNing, R. Devillier, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New developments in the use of apheresis to collect haematopoietic cells for cell transplantation and cell therapies

C. Chabannon, C. Faucher, A. Granata, 2016 .

Characterisation of Genome-Wide PLZF/RARA Target Genes

F. Bertucci, S. Spicuglia, K. Mills, 2011, PloS one.

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

F. Bertucci, P. Viens, C. Tarpin, 2016, European journal of cancer.

From clinical proof-of-concept to commercialization of CAR T cells.

C. Chabannon, B. Mfarrej, B. Calmels, 2018, Drug discovery today.

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

D. Blaise, D. Coso, C. Chabannon, 2013, Bone Marrow Transplantation.

Accreditation and regulations in cell therapy

E. Rial‐Sebbag, C. Chabannon, I. Slaper-Cortenbach, 2016 .

Long‐term outcome after allogeneic stem‐cell transplantation with reduced‐intensity conditioning in patients with multiple myeloma

R. Bouabdallah, D. Blaise, D. Coso, 2013, American journal of hematology.

Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma.

R. Bouabdallah, A. Santoro, D. Blaise, 2020, Blood advances.

707. Retroviral insertion site analysis in rhesus macaques transplanted with CD34+ hematopoietic stem cells transduced with a simian immunodeficiency virus-based lentiviral vector

A. Nienhuis, J. Gray, C. Dunbar, 2004 .

Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA

J. Nunès, C. Chabannon, C. Tonnelle, 2008, Gene Therapy.

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

F. Bertucci, P. Viens, C. Tarpin, 2016, Bone Marrow Transplantation.

Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in children.

H. Chambost, C. Chabannon, A. Loundou, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia.

C. von Kalle, A. Nienhuis, C. A. Blau, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.

C. von Kalle, M. Laukkanen, C. Dunbar, 2005, Blood.

Low-dose total body irradiation causes clonal fluctuation of primate hematopoietic stem and progenitor cells.

C. von Kalle, M. Laukkanen, C. Dunbar, 2005, Blood.

CD34+ progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation

B. Esterni, H. Chambost, C. Chabannon, 2007, Bone Marrow Transplantation.

Assessing the HLA diversity of cord blood units collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan area

M. Gamerre, C. Chabannon, C. Picard, 2014, Transfusion.

showed to be effective in preventing bleeding events.

D. Blaise, C. Oudin, C. Chabannon, 2013 .

Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma

R. Bouabdallah, B. Esterni, D. Blaise, 2013, Leukemia and Lymphoma.

Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation

R. Bouabdallah, D. Blaise, R. Devillier, 2019, Bone Marrow Transplantation.

HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.

D. Blaise, R. Devillier, S. Harbi, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF

D. Blaise, J. Chiaroni, C. Chabannon, 2020, PloS one.

Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells

Christof von Kalle, Manfred Schmidt, Peiman Hematti, 2004, PLoS biology.

Recurrent Retroviral Vector Integration at the MDS1-EVI1 Locus in Rhesus Long-Term Repopulating Hematopoietic Stem Cells.

M. Laukkanen, C. Dunbar, R. Donahue, 2004 .

CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.

N. Kröger, D. Blaise, C. Chabannon, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.

D. Blaise, R. Devillier, S. Harbi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m2 intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia

D. Blaise, R. Devillier, S. Harbi, 2016, Leukemia & lymphoma.

Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.

R. Bouabdallah, B. Esterni, D. Blaise, 2010, Experimental hematology.

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus on Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

R. Bouabdallah, D. Blaise, R. Devillier, 2012, Mediterranean journal of hematology and infectious diseases.

Manufacturing Natural Killer Cells as Medicinal Products

Eric Vivier, Christian Chabannon, D. Blaise, 2016, Front. Immunol..

Comparable outcomes between unrelated and related donors after reduced‐intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high‐risk multiple myeloma

R. Bouabdallah, D. Blaise, D. Coso, 2012, European journal of haematology.

The Cleavage/Polyadenylation Activity Triggered by a U-rich Motif Sequence Is Differently Required Depending on the Poly(A) Site Location at Either the First or Last 3′-Terminal Exon of the 2′-5′ Oligo(A) Synthetase Gene*

Y. Aissouni, B. Calmels, Christophe Perez, 2002, The Journal of Biological Chemistry.

Ikaros Gene Expression and Leukemia

J. Gabert, C. Chabannon, C. Tonnelle, 2002, Leukemia & lymphoma.

Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell grafts.

C. Chabannon, P. Houzé, C. Lemarié, 2017, Cytotherapy.

Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells

C. Chabannon, A. Granata, C. Lemarié, 2022, Journal of Translational Medicine.

A matched‐pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution

D. Blaise, R. Devillier, S. Harbi, 2019, Transfusion.

Bone marrow processing for hematopoietic stem cell transplantation: recommendations of the SFGM-TC

J. D. Vos, I. Yakoub-Agha, C. Chabannon, 2015 .

Automated washing of autologous hematopoietic stem cell grafts after thawing does not impair engraftment

R. Bouabdallah, D. Coso, C. Chabannon, 2014, Bone Marrow Transplantation.

M. Fays, D. Blaise, C. Chabannon, 2021, Bone Marrow Transplantation.

[Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches].

D. Olive, D. Blaise, M. Mohty, 2003, Bulletin du Cancer.

An intra-patient comparison of blood cell separators Spectra and Optia in patients and donors undergoing blood mononuclear cell collections at a single institution for subsequent autologous or allogeneic hematopoietic cell transplantation reveals comparable collection efficiencies

C. Chabannon, A. Granata, C. Lemarié, 2016, Bone Marrow Transplantation.

Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product

B. Esterni, E. Deconinck, D. Coso, 2007, Transfusion.

Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate

R. Bouabdallah, D. Blaise, P. Viens, 2005, Transfusion.

Preclinical evaluation of an automated closed fluid management device: CytomateTM, for washing out DMSO from hematopoietic stem cell grafts after thawing

C. Chabannon, P. Houzé, B. Calmels, 2003, Bone Marrow Transplantation.

Validation of a semi automatic device to standardize quantification of Colony-Forming Unit (CFU) on hematopoietic stem cell products.

C. Chabannon, C. Lemarié, B. Calmels, 2019, Cytotherapy.

Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft‐versus‐host disease in reduced‐intensity conditioning transplantation for hematologic diseases

R. Bouabdallah, B. Esterni, D. Blaise, 2013, Cancer.

Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma.

D. Blaise, C. Oudin, C. Chabannon, 2012, Experimental hematology.

Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients

R. Bouabdallah, D. Blaise, R. Devillier, 2018, Bone Marrow Transplantation.

The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

R. Bouabdallah, A. Santoro, D. Blaise, 2016, Bone Marrow Transplantation.

A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor

R. Bouabdallah, D. Blaise, D. Coso, 2014, American journal of hematology.

Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products.

C. Chabannon, C. Lemarié, B. Mfarrej, 2020, Cytotherapy.

Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients

R. Bouabdallah, D. Blaise, R. Devillier, 2019, Bone Marrow Transplantation.

Long-Term Outcome of Second Allogeneic Hematopoietic Stem Cell Transplantation as Salvage Therapy for Young Patients after Relapse or Graft Failure: Experience at a Single Institution

D. Blaise, M. Mohty, N. Vey, 2013 .

Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation

D. Blaise, C. Oudin, C. Chabannon, 2012, American journal of hematology.

[Modalities for preparation, cryopreservation, thawing of hematopoietic stem cells and precautions for infusion to patient: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, M. Lacassagne, F. Pouthier, 2016, Bulletin du cancer.

Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL

D. Blaise, M. Mohty, N. Vey, 2003, Bone Marrow Transplantation.

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

F. Bertucci, P. Viens, C. Tarpin, 2017, Bone Marrow Transplantation.

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation

F. Bertucci, D. Birnbaum, P. Finetti, 2019, Clinical Epigenetics.

Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experience.

R. Bouabdallah, D. Blaise, C. Oudin, 2013, Experimental hematology.

Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.

R. Bouabdallah, D. Blaise, C. Oudin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells

D. Blaise, R. Devillier, S. Harbi, 2018, British journal of haematology.

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML

D. Blaise, R. Devillier, S. Harbi, 2017, Bone Marrow Transplantation.

Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor

D. Olive, D. Blaise, R. Devillier, 2020, Cancers.

Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.

D. Blaise, R. Devillier, S. Harbi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic origin.

D. Blaise, C. Chabannon, H. de Lavallade, 2009, Blood.

Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma.

R. Bouabdallah, D. Blaise, M. Mohty, 2011, Hematology/oncology and stem cell therapy.

Impact of CD34‐positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG‐based reduced intensity conditioning regimen

D. Blaise, R. Devillier, S. Harbi, 2017, American journal of hematology.

[Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, J. de Vos, J. Bay, 2018, Bulletin du cancer.

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study

F. Bertucci, P. Viens, C. Tarpin, 2016, Journal of Cancer.

[Academic cell therapy facilities are challenged by European regulation on advanced therapy medicinal products].

E. Rial‐Sebbag, C. Chabannon, G. Magalon, 2014, Medecine sciences : M/S.

PcG methylation of the HIST1 cluster defines an epigenetic marker of acute myeloid leukemia

S. Spicuglia, D. Grimwade, G. Bidaut, 2014, Leukemia.

Impact of antithymocyte globulin on the need for platelet transfusions during reduced-intensity conditioning administration before allogeneic stem cell transplantation.

D. Blaise, C. Oudin, C. Chabannon, 2013, Experimental hematology.

Characterisation of Genome-Wide PLZF/RARA Target Genes

F. Bertucci, S. Spicuglia, K. Mills, 2011, PloS one.

D. Blaise, R. Devillier, S. Harbi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A new single-platform method for the enumeration of CD34+ cells.

C. Chabannon, C. Lemarié, B. Calmels, 2009, Cytotherapy.

GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation

D. Blaise, R. Devillier, S. Harbi, 2023, Bone Marrow Transplantation.

R. Bouabdallah, B. Esterni, D. Blaise, 2013, Cancer.

[CD34+ cell selection methods, quality controls and expected results: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, B. Calmels, E. Magrin, 2020, Bulletin du cancer.